스캐폴드 기술 시장 규모, 점유율, 성장 분석 : 유형별, 소재별, 질환 유형별, 용도별, 최종 용도별, 지역별 - 산업 예측(2025-2032년)
Scaffold Technology Market Size, Share, Growth Analysis, By Type (Hydrogels, Polymeric Scaffolds), By Material (Bio-inert, Bioresorbable), By Disease Type, By Application, By End-Use, By Region - Industry Forecast 2025-2032
상품코드 : 1630725
리서치사 : SkyQuest
발행일 : 2025년 01월
페이지 정보 : 영문 157 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ₩ 7,850,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ₩ 9,183,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ₩ 10,516,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 스캐폴드 기술 시장 규모는 2023년에 19억 8,000만 달러로 평가되며, 2024년 22억 5,000만 달러에서 2032년에는 63억 4,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 13.8%로 성장할 전망입니다.

스캐폴드 기술 시장은 장기 이식 및 재건 치료에 대한 전 세계 수요 증가로 인해 장기 기능 부전 환자 증가로 인해 크게 성장하고 있습니다. 조직공학 및 재생의학에서 종종 고분자 바이오소재로 만들어진 스캐폴더는 세포에 필수적인 구조적 지지대를 제공하여 새로운 조직 형성을 촉진합니다. 조직 공학의 세 가지 요소는 세포, 스캐폴더, 성장인자로 구성되며, 스캐폴더는 섬유질, 다공성, 하이드로겔 형태로 분류됩니다. 비계의 성공 여부는 생체 적합성, 기계적 특성, 생분해성 등 중요한 요소에 달려 있습니다. 또한 첨단 3D 매트릭스 개발을 위한 생명공학 기업의 R&D 투자 증가는 시장 발전을 촉진하고 있습니다. 전반적으로 스캐폴드 기술의 기술 혁신과 조직 공학에 대한 강조는 이 시장의 견고한 성장 잠재력을 지원하고 있습니다.

목차

서론

조사 방법

개요

시장 역학과 전망

주요 시장 인사이트

스캐폴드 기술 시장 규모 : 유형별

스캐폴드 기술 시장 규모 : 소재별

스캐폴드 기술 시장 규모 : 질환 유형별

스캐폴드 기술 시장 규모 : 용도별

스캐폴드 기술 시장 규모 : 최종 용도별

스캐폴드 기술 시장 규모

경쟁 정보

주요 기업 개요

결론과 권장사항

KSA
영문 목차

영문목차

Global Scaffold Technology Market size was valued at USD 1.98 billion in 2023 and is poised to grow from USD 2.25 billion in 2024 to USD 6.34 billion by 2032, growing at a CAGR of 13.8% during the forecast period (2025-2032).

The scaffold technology market is experiencing significant growth, driven by rising global demand for organ transplants and reconstruction therapies due to an increasing number of patients with critical non-functioning organs. Using tissue engineering and regenerative medicine, scaffolds-often created from polymeric biomaterials-provide essential structural support for cells, facilitating the formation of new tissue. The tissue engineering triad comprises cells, scaffolds, and growth factors, with scaffolds categorized into fibrous, porous, and hydrogel types. The success of scaffolds hinges on crucial factors like biocompatibility, mechanical properties, and biodegradability. Furthermore, heightened R&D investments by biotechnology firms in developing advanced 3D matrices are propelling market advancements. Overall, innovations in scaffold technology and a growing emphasis on tissue engineering underscore this market's robust expansion potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Scaffold Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Scaffold Technology Market Segmental Analysis

Global Scaffold Technology Market is segmented by Type, Material, Disease Type, Application, End-Use and region. Based on Type, the market is segmented into Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds. Based on Material, the market is segmented into Bio-inert, Bioresorbable and Bioactive. Based on Disease Type, the market is segmented into Orthopedics, Musculoskeletal, Spine, Cancer, Skin, Integumentary, Dental, Cardiology & Vascular, Neurology, Urology, GI & Gynecology and Others. Based on Application, the market is segmented into Stem Cell Therapy, Regenerative Medicine, Tissue Engineering, Cancer cell research, Drug Discovery and Others. Based on End-Use, the market is segmented into Biotechnology & Pharmaceutical Organizations, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Scaffold Technology Market

The Global Scaffold Technology market is significantly influenced by several key drivers, including the advancement of regenerative technologies and their expanding applications. A rise in accidents leading to organ damage is expected to bolster the need for scaffold technology further. Moreover, the growing aging population may pose a challenge to market growth. Nevertheless, the escalating demand for tissue engineering and reconstructive surgeries, the widespread adoption of biomaterials, along with continuous technological innovations in scaffold technology, are the primary factors propelling the market forward. This combination of demand increase and technological development is essential for the market's success and sustainability.

Restraints in the Global Scaffold Technology Market

The Global Scaffold Technology market faces several constraints impacting its revenue growth during the forecast period. Notably, the rise of scaffold-free methodologies for multi-dimensional cell culture, along with the advancement of matrix-based 3D cellular models, has resulted in mixed outcomes. High implementation costs associated with these technologies further hinder market expansion. Additionally, the introduction of scaffold-free cell culture alternatives is likely to pose a challenge to traditional scaffold solutions. However, there exists significant growth potential in emerging nations, particularly if their governments increase investment in research and development, which could drive innovation and market opportunities in the region.

Market Trends of the Global Scaffold Technology Market

The Global Scaffold Technology market is poised for significant growth driven by advances in synthetic scaffold materials, particularly within tissue engineering. Innovations across genetics, pharmaceuticals, and materials science are aligning to enhance the efficacy and applicability of scaffolds in regenerative medicine. This is particularly critical in addressing the disparity between organ supply and demand for transplantation among patients with terminal conditions. As the need for viable organ alternatives escalates, scaffold technology emerges as a pivotal solution, catalyzing market expansion and attracting investment in research and development, ultimately promising improved patient outcomes and healthcare solutions in the coming years.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Scaffold Technology Market Size by Type & CAGR (2025-2032)

Global Scaffold Technology Market Size by Material & CAGR (2025-2032)

Global Scaffold Technology Market Size by Disease Type & CAGR (2025-2032)

Global Scaffold Technology Market Size by Application & CAGR (2025-2032)

Global Scaffold Technology Market Size by End-Use & CAGR (2025-2032)

Global Scaffold Technology Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기